Yahoo Finance

Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

MEQUON, Wis. and LENEXA, Kan., July 28, 2026 /PRNewswire/ -- LyoGenesis Plus 1, LLC ("LyoGenesis Plus"), a company related to Vector Science & Therapeutics Corp. ("Vector"), and Wynn Pharmaceuticals ...
FT Markets

Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online

Milestone facility meets cGMP, FDA, and ISO quality standards on schedule; remaining three suites to launch in September ...

Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides

Vector Science and Therapeutics Corp. ("Vector" or the "Company") (TSXV: PAIN) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office ...
Morningstar%2c Inc.

Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform

14-Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less MEQUON, Wis., June 12, 2026 /PRNewswire/ -- ...